ESR1 and breast cancer: Furthermore, we compared enrichment of known ERα transcriptional targets specific to normal breast or breast cancer [23] in the RigoSig gene set and found ERα targets from normal breast to be significantly enriched upon PLK1 inhibition, while ERα breast cancer targets were not (Fig. S5C).